The Calmer Co International Ltd (asx:CCO) Share Price

Company Profile

Business description
The Calmer Co International Ltd is mainly engaged in the research, development, and selling of kava extracts as a consumer product. Its business objective is the primary production of kava through a network of outsourced kava farms and via its Farm located in Fiji and the production and sale of kava supplements and complementary medicines. The company has produced three types of products in the market: shots, powders, and capsules. Its reportable segments are; Fiji Kava Australia Trading Pty Ltd (Fiji Kava Australia Trading) which derives maximum revenue, South Pacific Elixirs Pty Limited (SPE Fiji), Fiji Kava Inc (USA), and Danodan Hempworks LLC (USA). Geographically, it derives key revenue from Australia and the rest from Fiji, and other regions.
Contact
Sector
Consumer Defensive
Stock type
Industry
Packaged Foods
Fiscal Year End
Employees

Recommended

Investors may be over optimistic about the prospects for a new revenue source.

Roy van Keulen | 02 March 2025

The longer term outlook for these moated companies looks far brighter than markets seem to be giving them credit for.

Joseph Taylor | 02 March 2025

Are the shares of two of Australia’s best known brands attractive?

Johannes Faul | 27 February 2025

Index	Last price	Change	% Change
All Ordinaries	8,448.30	44.40	0.53%
CAC 40	8,111.63	9.11	0.11%
DAX 40	22,551.43	0.54	0.00%
Dow JONES (US)	43,840.91	601.41	1.39%
FTSE 100	8,809.74	53.53	0.61%
HKSE	22,941.32	776.97	-3.28%
NASDAQ	18,847.28	302.86	1.63%
Nikkei 225	37,155.50	1,100.67	-2.88%
NZX 50 Index	12,521.11	80.31	-0.64%
S&P 500	5,954.50	92.93	1.59%
S&P/ASX 200	8,218.00	45.60	0.56%
SSE Composite Index	3,320.90	67.17	-1.98%